hydroxypropylmethylcellulose acetate succinate has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akalkotkar, A; Chablani, L; Chiriva-Internati, M; D'Souza, C; D'Souza, MJ; Selvaraj, P; Tawde, SA | 1 |
1 other study(ies) available for hydroxypropylmethylcellulose acetate succinate and Ovarian Neoplasms
Article | Year |
---|---|
Formulation and evaluation of oral microparticulate ovarian cancer vaccines.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Neoplasm; B-Lymphocytes; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemistry, Pharmaceutical; Drug Carriers; Female; Humans; Interleukins; Methylcellulose; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Polymethacrylic Acids; Treatment Outcome | 2012 |